Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020 Background Interleukin 6 concentration is associated with myocardial injury, heart failure, and mortality after myocardial infarction. In the Norwegian tocilizumab non–ST‐segment–elevation myocardial infarction trial, the first randomized trial of ...
Marc J. George +12 more
doaj +1 more source
Evidence for mechanisms underlying the functional benefits of a myocardial matrix hydrogel for post-MI treatment [PDF]
, 2016 Background There is increasing need for better therapies to prevent the development of heart failure after myocardial infarction (MI). An injectable hydrogel derived from decellularized porcine ventricular myocardium has been shown to halt the post ...
Braden, Rebecca L. +8 more
core +1 more source
Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms [PDF]
, 2016 A growing body of evidence suggests that atrial fibrillation (AF) is associated with myocardial infarction (MI). However, incidence and management of MI in AF is still undefined. METHODS AND RESULTS: We searched MEDLINE via PubMed and Cochrane database
PASTORI, DANIELE +3 more
core +1 more source
Plasma Atherogenic Index Predicts Malignant Arrhythmias in Non–STElevation Myocardial Infarction
Eurasian Journal of MedicineBackground: Malignant ventricular arrhythmias are serious complications of non–ST-elevation myocardial infarction. The plasma atherogenic index, derived from triglyceride and high-density lipoprotein cholesterol, reflects atherogenic dyslipidemia.
Alperen Taş +2 more
doaj +1 more source
Outcome of very elderly (octogenarians) patients with coronary artery disease, all diagnosed by coronary angiography [PDF]
, 2017 Background: Women with ischemic heart disease (IHD) typically present less severe coronary artery atherosclerosis. Despite that, as compared with men, women maintain a worse outcome.
Arrivi, Alessio +8 more
core +1 more source
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy. [PDF]
, 2017 Bone marrow mononuclear cell (BM-MNC) therapy in ST-elevation acute myocardial infarction (STEMI) has no biological inclusion criteria. Here, we analyzed 63 biomarkers and cytokines in baseline plasma samples from 77 STEMI patients treated with BM-MNCs ...
Bolli, Roberto +16 more
core
Treatment of NSTEMI (Non-ST Elevation Myocardial Infarction) [PDF]
Current Emergency and Hospital Medicine Reports, 2013 Non-ST elevation myocardial infarction (NSTEMI) is a recognized diagnostic entity that has an unacceptable mortality rate when it goes unrecognized. Following diagnosis, initial treatment with analgesics, nitrates and anti-platelet agents forms the initial approach. New anti-platelet agents such as ticagrelor and prasugrel need to be clearly understood.
V. Anantharaman, Swee Han Lim
openaire +1 more source
Intramyocardial hemorrhage: An enigma for cardiac MRI? [PDF]
, 2015 Cardiovascular magnetic resonance (CMR) is a useful noninvasive technique for determining the presence of microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH), frequently occurring in patients after reperfused myocardial infarction (MI ...
Calvieri, Camilla +5 more
core +4 more sources
Clinical utility of cardiac troponin measurement in COVID-19 infection [PDF]
, 2020 The novel coronavirus SARS-CoV-2 causes the disease COVID-19, a severe acute respiratory syndrome. COVID-19 is now a global pandemic and public health emergency due to rapid human-to-human transmission.
Gaze, D.C., Gaze, D.C.
core +1 more source
Evidence-Informed Case Rates: A New Health Care Payment Model [PDF]
, 2007 Suggests a new payment model whereby providers are paid a single, risk-adjusted payment across inpatient and outpatient settings to care for a patient diagnosed with a specific ...
Francois de Brantes, Joseph A. Camillus
core